These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38007477)

  • 41. Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosis.
    Shewade HD; Gupta V; Satyanarayana S; Kharate A; Sahai KN; Murali L; Kamble S; Deshpande M; Kumar N; Kumar S; Pandey P; Bajpai UN; Tripathy JP; Kathirvel S; Pandurangan S; Mohanty S; Ghule VH; Sagili KD; Prasad BM; Nath S; Singh P; Singh K; Singh R; Jayaraman G; Rajeswaran P; Srivastava BK; Biswas M; Mallick G; Bera OP; Jaisingh AJJ; Naqvi AJ; Verma P; Ansari MS; Mishra PC; Sumesh G; Barik S; Mathew V; Lohar MRS; Gaurkhede CS; Parate G; Bale SY; Koli I; Bharadwaj AK; Venkatraman G; Sathiyanarayanan K; Lal J; Sharma AK; Rao R; Kumar AMV; Chadha SS;
    Glob Health Action; 2018; 11(1):1494897. PubMed ID: 30173603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Closing the Evidence Gap of Cash Transfer for Tuberculosis-Affected Households Comment on "Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? - A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India".
    Fuady A
    Int J Health Policy Manag; 2023; 12():7658. PubMed ID: 37579478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "I'm suffering for food": Food insecurity and access to social protection for TB patients and their households in Cape Town, South Africa.
    Vanleeuw L; Zembe-Mkabile W; Atkins S
    PLoS One; 2022; 17(4):e0266356. PubMed ID: 35472210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 2020 baseline assessment for the monitoring of the End TB indicator of catastrophic costs in Burkina Faso.
    Diallo A; Combary A; Bakyono R; Guene H; Ouedraogo S; Garcia Baena I; Moyenga L; Berthe A; Dahourou DL; Nguhiu P; Laokri S
    Int J Tuberc Lung Dis; 2022 Oct; 26(10):970-977. PubMed ID: 36163665
    [No Abstract]   [Full Text] [Related]  

  • 46. Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.
    Yamanaka T; Castro MC; Ferrer JP; Solon JA; Cox SE; Laurence YV; Vassall A
    PLoS One; 2024; 19(1):e0297342. PubMed ID: 38271328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The economic burden of TB-affected households in DR Congo.
    Kaswa M; Minga G; Nkiere N; Mingiedi B; Eloko G; Nguhiu P; Baena IG
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):923-932. PubMed ID: 34686235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.
    Verguet S; Riumallo-Herl C; Gomez GB; Menzies NA; Houben RMGJ; Sumner T; Lalli M; White RG; Salomon JA; Cohen T; Foster N; Chatterjee S; Sweeney S; Baena IG; Lönnroth K; Weil DE; Vassall A
    Lancet Glob Health; 2017 Nov; 5(11):e1123-e1132. PubMed ID: 29025634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Loveday M; Sunkari B; Master I; Daftary A; Mehlomakulu V; Hlangu S; Marais BJ
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):40-46. PubMed ID: 29297424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal.
    Gurung SC; Dixit K; Rai B; Caws M; Paudel PR; Dhital R; Acharya S; Budhathoki G; Malla D; Levy JW; van Rest J; Lönnroth K; Viney K; Ramsay A; Wingfield T; Basnyat B; Thapa A; Squire B; Wang D; Mishra G; Shah K; Shrestha A; de Siqueira-Filha NT
    Infect Dis Poverty; 2019 Dec; 8(1):99. PubMed ID: 31791412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of Household Catastrophic Total Cost of Tuberculosis and Its Determinants in Cairo: Prospective Cohort Study.
    Ellaban MM; Basyoni NI; Boulos DNK; Rady M; Gadallah M
    Tuberc Respir Dis (Seoul); 2022 Apr; 85(2):165-174. PubMed ID: 34814238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher loss of livelihood and impoverishment in households affected by tuberculosis compared to non-tuberculosis affected households in Zimbabwe: a cross-sectional study.
    Timire C; Houben RM; Pedrazzoli D; Ferrand RA; Calderwood CJ; Bond V; Mbiba F; Kranzer K
    medRxiv; 2023 Dec; ():. PubMed ID: 38106129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review.
    Barter DM; Agboola SO; Murray MB; Bärnighausen T
    BMC Public Health; 2012 Nov; 12():980. PubMed ID: 23150901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protocol for the Addressing the Social Determinants and Consequences of Tuberculosis in Nepal (ASCOT) pilot trial.
    Rai B; Dixit K; Dhital R; Rishal P; Gurung SC; Paudel PR; Mishra G; Bonnett L; Siqueira-Filha N; Khanal MN; Lonnroth K; Squire SB; Caws M; Wingfield T
    Wellcome Open Res; 2022; 7():141. PubMed ID: 36874579
    [No Abstract]   [Full Text] [Related]  

  • 55. Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India.
    Prasanna T; Jeyashree K; Chinnakali P; Bahurupi Y; Vasudevan K; Das M
    Glob Health Action; 2018; 11(1):1477493. PubMed ID: 29902134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
    Odongo D; Omech B; Acanga A
    PLoS One; 2023; 18(12):e0288761. PubMed ID: 38127969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing disease specific catastrophic cost estimates using longitudinal and cross-sectional designs: The example of tuberculosis.
    Yamanaka T; Castro MC; Ferrer JP; Cox SE; Laurence YV; Vassall A
    Soc Sci Med; 2024 Mar; 344():116631. PubMed ID: 38308959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barriers and facilitators to accessing tuberculosis care in Nepal: a qualitative study to inform the design of a socioeconomic support intervention.
    Dixit K; Biermann O; Rai B; Aryal TP; Mishra G; Teixeira de Siqueira-Filha N; Paudel PR; Pandit RN; Sah MK; Majhi G; Levy J; Rest JV; Gurung SC; Dhital R; Lönnroth K; Squire SB; Caws M; Sidney K; Wingfield T
    BMJ Open; 2021 Oct; 11(10):e049900. PubMed ID: 34598986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda.
    Samuels THA; Shete PB; Ojok C; Nalugwa T; Farr K; Turyahabwe S; Katamba A; Cattamanchi A; Moore DAJ
    PLoS One; 2021; 16(7):e0253927. PubMed ID: 34270582
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.